CJC-1295
Extended-Release GH Optimization
A long-acting GHRH analog often paired with Ipamorelin for synergistic GH release, promoting sustained muscle growth and fat metabolism.
Prescription Required
Can't get CJC-1295 through your GP? These telemedicine providers specialize in peptide therapy.
Everlywell
FDA-approved tesamorelin and comprehensive peptide therapy with at-home testing.
Hone Health
Hormone optimization & peptide therapy for men. At-home testing with physician oversight.
Marek Health
Comprehensive hormone and peptide protocols with detailed blood work analysis.
Everlife.md
Peptide-focused telemedicine platform with personalized protocols and ongoing monitoring.
Peter MD
Telemedicine platform specializing in peptide therapy and hormone optimization.
Defy Medical
Established telemedicine clinic offering peptides, HRT, and regenerative therapies.
Always consult with a licensed physician before starting any peptide therapy.
About CJC-1295
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a key modification: the addition of a Drug Affinity Complex (DAC) that extends its half-life from minutes to approximately one week. This means sustained, elevated GH levels rather than brief spikes. CJC-1295 is most commonly used in combination with Ipamorelin, creating a powerful synergy—CJC-1295 amplifies the GH pulse while Ipamorelin triggers it. This combination is considered the gold standard for peptide-based GH optimization.
Mechanism of Action
CJC-1295 binds to GHRH receptors and stimulates GH release, but its DAC modification allows it to bind to albumin in the bloodstream, dramatically extending its active life. This creates a sustained elevation of GH and IGF-1 levels over days rather than hours, promoting continuous anabolic and recovery benefits.
How CJC-1295 Works in Your Body:
- Target Receptors: CJC-1295 binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
- Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
- Timeline: Effects typically begin within 1-2 weeks, with optimal results seen over the recommended protocol duration.
Dosing Protocol
Frequency
2-3 times weekly (with DAC) or daily (without DAC)
Timing
Evening administration preferred
Duration
12-16 week cycles
Important Notes
1-2mg per week total when using CJC-1295 with DAC. Often combined with 200mcg Ipamorelin per dose.
Clinical Research
3 studies on CJC-1295
Half-Life Extension Study
CJC-1295 with DAC showed a half-life of 5.8-8.1 days compared to 30 minutes for native GHRH.
Journal of Clinical Endocrinology & Metabolism
IGF-1 Elevation
Single dose elevated IGF-1 levels by 2-3x for up to 10 days in healthy adults.
Growth Hormone & IGF Research
Synergy with Ipamorelin
Combination therapy showed 3x greater GH response compared to either peptide alone.
Peptides Journal
Growth Hormone Peptides Compared
Compare mechanism of action, FDA status, and use cases for the most popular growth hormone releasing peptides.
| Peptide | FDA Status | Mechanism | GH Release | Side Effects | Best For | Details |
|---|---|---|---|---|---|---|
Tesamorelin FDA-Approved GHRH Analog | FDA Approved | Binds GHRH receptors on pituitary, stimulating natural GH synthesis and pulsatile release | strong | moderate | Those seeking FDA-approved option for visceral fat reduction with physician oversight | View |
Sermorelin The Gold Standard GHRH | Compounded | First 29 amino acids of GHRH, triggers natural pulsatile GH release during sleep | moderate | minimal | Beginners seeking gentle GH optimization with excellent safety profile | View |
CJC-1295 Extended-Release GHRH | Research | Modified GHRH with DAC for extended half-life, sustained GH elevation over days | strong | moderate | Those wanting less frequent dosing with sustained GH benefits | View |
Ipamorelin Clean GH Secretagogue | Research | Selective ghrelin receptor agonist, triggers GH pulse without affecting cortisol/prolactin | moderate | minimal | Those wanting clean GH elevation without hormonal disruption | View |
Tesamorelin
FDA-Approved GHRH Analog
GH Release
Side Effects
Primary Uses
Those seeking FDA-approved option for visceral fat reduction with physician oversight
Learn MoreSermorelin
The Gold Standard GHRH
GH Release
Side Effects
Primary Uses
Beginners seeking gentle GH optimization with excellent safety profile
Learn MoreCJC-1295
Extended-Release GHRH
GH Release
Side Effects
Primary Uses
Those wanting less frequent dosing with sustained GH benefits
Learn MoreIpamorelin
Clean GH Secretagogue
GH Release
Side Effects
Primary Uses
Those wanting clean GH elevation without hormonal disruption
Learn MoreFDA-Approved Option
Tesamorelin is the only FDA-approved GHRH analog, offering the highest level of regulatory oversight for visceral fat reduction.
Beginner-Friendly
Sermorelin and Ipamorelin offer excellent tolerability profiles, making them ideal starting points for GH optimization.
Synergistic Stacking
GHRH peptides (Sermorelin, CJC-1295) can be stacked with GHRPs (Ipamorelin) for enhanced, synergistic GH release.
CJC-1295 in Practice
Who CJC-1295 is for
Adults pursuing GH optimization for body composition, recovery, sleep, and longevity. CJC-1295 (no DAC, also called Mod GRF 1-29) is the standard GHRH partner for ipamorelin in modern peptide stacks. The DAC version is used by people who want a continuous GH bleed effect rather than physiological pulses — but most experts prefer no-DAC for daily use.
Who should avoid it
Active malignancy, pregnancy, uncontrolled diabetes, history of pituitary tumors. The DAC version specifically should be avoided by anyone wanting natural pulsatile GH or who is sensitive to elevated baseline IGF-1.
Clinical Context
CJC-1295 is a synthetic GHRH analog. It comes in two versions: 'no DAC' (modified GRF 1-29, half-life ~30 minutes — produces physiological GH pulses) and 'with DAC' (drug affinity complex extends half-life to 6-8 days — produces continuous GH elevation). The no-DAC version is the standard for daily use, almost always paired with ipamorelin to engage both the GHRH and ghrelin receptor pathways for a synergistic 2-4x GH pulse. Standard protocol is 100 mcg subcutaneously, 1-3 times daily, on an empty stomach.
Common Mistakes to Avoid
Confusing DAC and no-DAC
These are functionally different drugs. No-DAC: pulses, used 1-3x daily, mimics physiology. DAC: continuous, used 1-2x weekly, raises baseline GH and IGF-1 chronically. Make sure you know which you're buying.
Using alone without ipamorelin
GHRH alone produces a small pulse. Add a GHRP (ipamorelin is the standard) for a synergistic effect. They're routinely co-administered in the same syringe.
Eating too soon after
Wait 20-30 minutes after dosing. Insulin blunts the GH pulse.
Using DAC daily
DAC's whole point is the long half-life. Daily DAC dosing causes IGF-1 to climb continuously — which is associated with negative longevity outcomes. If you use DAC, dose 1-2x weekly maximum.
CJC-1295 Variants Compared
| Compound | Compared to | Verdict |
|---|---|---|
| CJC-1295 no DAC | CJC-1295 with DAC | No DAC: pulsatile, physiological, daily. DAC: continuous, supraphysiological, weekly. Most experts prefer no DAC for daily use. |
| CJC-1295 no DAC | Sermorelin | Same mechanism (GHRH analog). CJC-1295 no DAC has a slightly longer half-life and tetrasubstitution for stability. Often interchangeable. |
| CJC-1295 + Ipamorelin | Either alone | Combined dosing produces 2-4x larger GH pulse than either compound alone. This is the standard modern stack. |
Important Safety Information
Medical Disclaimer: The information provided about CJC-1295 is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or peptide protocol.
Research Status: While CJC-1295 has shown promising results in research studies, many peptides are still being studied and may not be approved by regulatory bodies like the FDA for specific uses. The research cited represents ongoing scientific investigation.
Individual Variation: Responses to peptides vary significantly between individuals. What works for one person may not work for another. Side effects, while generally mild, can occur and should be monitored closely.
Quality & Sourcing: If you choose to use peptides, ensure you obtain them from reputable, tested sources. Peptide quality, purity, and proper storage are critical for safety and efficacy.
Legal Considerations: Peptide regulations vary by country and jurisdiction. Some peptides may require a prescription or may have restrictions on their use. Research the laws in your area before obtaining or using peptides.